Search
for
Sort by
Research 511–540 of 1000+
- Ayurvedic Management of Seborrheic Dermatitis
- Alopecia areata during the convalescent phase of kawasaki disease
- A randomized, double blind, placebo controlled, split patch study to evaluate the effects of platelet rich plasma on alopecia areata
- Alopecia
- Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata
- Concomitant acute alopecia and profound bone marrow suppression: An unusual manifestation of azathioprine toxicity
- Lichen planopilaris associated with hair extensions in a patient with alopecia areata: A case report
- Abrocitinib in the Treatment of Severe Alopecia Areata in a Pediatric Patient: A Case Report
- Diagnosis and treatment of Microsporum canis-induced dermatophytosis in a domestic cat
- Association of lupus and a frontal fibrosing alopecia: A case report
- Baseline methotrexate does not impact the incidence of infliximab infusion reactions: Results from a Canadian real-world treatment registry
- Race and Alopecia Areata amongst US Women
- A man with changes on nose
- Atopic dermatitis and risk of autoimmune diseases: a systematic review and meta-analysis
- Alopecia in lupus: Experience from a tertiary referral centre
- Videodermoscopy in the evaluation of hair and scalp disorders
- Alopecia Areata: An Updated Review for 2023
- Review of quality of life studies in women with alopecia
- Hair regrowth in alopecia areata patients following Stem Cell Educator therapy
- Role of janus kinase inhibitors in the treatment of alopecia areata
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Three cases of immune‐mediated adnexal skin disease treated with cyclosporin
- Hair loss in children: Common and uncommon causes; clinical and epidemiological study in Jordan
- The Basic Science of Hair Biology
- Immune cell regulation of the hair cycle
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations
- Phenotypic Analysis of T-Cells in Extensive Alopecia Areata Scalp Suggests Partial Tolerance
- Serum Vitamin D levels and Alopecia areata- A hospital based case-control study from North-India
- Cancer risk in patients with alopecia areata: a nationwide population‐based matched cohort study